Question: What is Tamiflu? Answer: It’s an antiviral drug that can stop flu viruses from multiplying in your body. It does not cure the flu, but it can make it somewhat less brutal and long-lasting.

While Tamiflu can be a lifesaver for those at high risk of complications from the virus, some question how much good it does for patients without pre-existing conditions. Feb. 12: Flu gone in a day?

Coming down with the flu is likely to mean spending several days in bed feeling lousy. But the flu can be far more serious. So far, this season’s flu is responsible for between 140,000 and 250,00 ...

Tamiflu is also widely available and there are multiple generic manufacturers of oseltamivir. There is sufficient supply of branded Tamiflu,” a company spokesperson said in a statement.

One is called oseltamivir, or also known as Tamiflu, and the other is known as zanamivir, also known as Relenza. Both of those are what are called neuraminidase inhibitor medications.

Tamiflu is a prescription antiviral medication used to minimize the symptoms of the flu. It works by attacking the flu virus early on to keep it from multiplying in your body.

It is not clear if Tamiflu can cause suicidal behavior. The drug's maker, Genentech, notes that flu itself "hallucinations, delirium and abnormal behavior, in some cases resulting in fatal outcomes".

Tamiflu is the most-prescribed treatment for the flu, and now, with H1N1 on the upswing, supplies of the kids' version of the antiviral drug -- the liquid form -- are running short.

The 16-year-old boy was diagnosed with the flu last Thursday, and like many flu patients, he was prescribed Tamiflu. "We started it right in the car, get it in him and get him started,” said Ray.

Because Tamiflu is known to have sometimes dangerous side effects, especially in kids, I’m interested to see what else comes of this story. British Medical Journal Slams Roche on Tamiflu [ABC News] ...

The flu fighter Tamiflu is one of the most recognizable antiviral medications in the world -- but its weaknesses suggest that devising a similarly simple treatment for Covid-19 will be challenging.

The WHO recently published a review of 39 Tamiflu-resistant cases -- the number it had counted as of October 22. Seven of them were immuno-compromised patients, like the recent clusters.